investing

Go-Anywhere Funds

Steve Romick hates to lose money.

Steve Romick hates to lose money. Recently, he's been making the most of the flexible mandate of FPA Crescent (FPACX) by reducing exposure to stocks and buying more bank loans. "Debt, debt, debt," he says, describing the pattern of his recent purchases.

The way Romick views the world, the economy will not recuperate and stocks cannot mount a sustainable recovery until yields on bonds other than those backed by the world's strongest nations come down and banks heal. So he'd much rather pick up senior bank debt of distressed corporations yielding 20% or more to maturity. He is also sticking with energy stocks. He figures that these companies will benefit over time, when inflation ticks up.

Bruce Berkowitz, of Fairholme fund (FAIRX), knew it would be bad, but he never expected it would be this bad. "We predicted rain, but we didn't build a strong-enough ark," he says. As the economy cuts back on debt and consumers struggle to rebuild household balance sheets, he's leaning toward businesses that derive much of their income courtesy of Uncle Sam. That helps explain the recent dramatic increase in Fairholme's allocation to health care and defense. "What's more important than the health and safety of your family?" Berkowitz quips.

He is also snapping up high-yielding bonds from outfits such as Hertz. "If we can get equity-like returns for our shareholders and do it in a safe position, why not buy bonds?" he asks.

Investing with the inimitable Ken Heebner, of CGM Focus (CGMFX), is always a bit of a roller-coaster ride, but the past two years have been ridiculous. In 2007, CGM Focus soared a majestic 80%. Then, in 2008, the fund fell back to earth, plummeting 48%.

When Heebner is on, he is really, really good. But when he's out of sync, he can be awful. Over the long haul, though, his results are quite stunning. At last check, Focus looked pretty tame, with about 10% of its assets in dependable Abbott Laboratories and 28% in insurance stocks.

Large-Company Funds
Small- and Mid-Cap Funds
Overseas/Global Funds
Commodity Fund
Bond Funds

Most Popular

The 11 Most Expensive Cities in the U.S.
real estate

The 11 Most Expensive Cities in the U.S.

From metro areas on both coasts to the middle of the Pacific Ocean, these are the priciest cities in the U.S. to call home.
August 9, 2022
Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
You'll Save More on Green Home Improvements Under the Inflation Reduction Act
Tax Breaks

You'll Save More on Green Home Improvements Under the Inflation Reduction Act

Tax credits for energy-efficient home improvements will be extended and expanded by the Inflation Reduction Act.
August 12, 2022

Recommended

3 Dated Rules of Thumb Retirees Should Think Twice About
investing

3 Dated Rules of Thumb Retirees Should Think Twice About

The tried-and-true investing and saving rules of thumb retirees depend on may no longer be as reliable as they hoped. Don’t let dated “rules” steer yo…
August 11, 2022
The Good News About Recessions for Investors
investing

The Good News About Recessions for Investors

Yes, an official recession is possible, but based on previous recessions, there could be reasons for investors to smile. With that in mind, here are t…
August 11, 2022
Has Inflation Peaked? Here's What the Experts Are Saying
investing

Has Inflation Peaked? Here's What the Experts Are Saying

Inflation decelerated by more than expected in July, but that doesn't mean our era of fast-rising prices – or Fed rate hikes – is over.
August 10, 2022
IRA Bill a Blessing in Disguise for Drug Stocks?
investing

IRA Bill a Blessing in Disguise for Drug Stocks?

Coming limits on drug pricing may not be bad news for drug makers after all.
August 10, 2022